Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

Synthesis and in vitro antimycobacterial activity of 2-methoxybenzanilides and their thioxo analogues

Ján Kozic, Eva Novotná, Marie Volková, Jiřina Stolaříková, František Trejtnar, Jarmila Vinšová

. 2012 ; 56 () : 387-395.

Language English Country France

Document type Journal Article, Research Support, Non-U.S. Gov't

Persistent link   https://www.medvik.cz/link/bmc13024342

Grant support
NS10367 MZ0 CEP Register
NT13346 MZ0 CEP Register

A new series of N-(3/4-substituted phenyl) 4/5-chloro-2-methoxybenzamides and their thioxo analogues have been synthesised and evaluated for in vitro antimycobacterial activity against Mycobacterium tuberculosis H37Rv, as well as the two atypical strains Mycobacterium kansasii and Mycobacterium avium. Five of the most active compounds were evaluated for cytotoxicity and their ability to inhibit mycobacterial isocitrate lyase, which is responsible for latent survival of Mycobacterium. The results showed that benzthioanilides were more active than the corresponding benzanilides. The most active compound, 4-chloro-2-methoxy-N-(3,4-dichlorophenyl)benzothioamide (4e), had a minimal inhibition concentration (MIC) against M. tuberculosis of 2 μmol L(-1), which was better than the activity of the previously published corresponding salicylanilide.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc13024342
003      
CZ-PrNML
005      
20181212112152.0
007      
ta
008      
130703s2012 fr f 000 0|eng||
009      
AR
024    7_
$a 10.1016/j.ejmech.2012.07.044 $2 doi
035    __
$a (PubMed)22907036
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a fr
100    1_
$a Kozic, Ján $u Department of Inorganic and Organic Chemistry, Faculty of Pharmacy in Hradec Králové, Charles University in Prague, Hradec Králové, Czech Republic $7 _AN044876
245    10
$a Synthesis and in vitro antimycobacterial activity of 2-methoxybenzanilides and their thioxo analogues / $c Ján Kozic, Eva Novotná, Marie Volková, Jiřina Stolaříková, František Trejtnar, Jarmila Vinšová
520    9_
$a A new series of N-(3/4-substituted phenyl) 4/5-chloro-2-methoxybenzamides and their thioxo analogues have been synthesised and evaluated for in vitro antimycobacterial activity against Mycobacterium tuberculosis H37Rv, as well as the two atypical strains Mycobacterium kansasii and Mycobacterium avium. Five of the most active compounds were evaluated for cytotoxicity and their ability to inhibit mycobacterial isocitrate lyase, which is responsible for latent survival of Mycobacterium. The results showed that benzthioanilides were more active than the corresponding benzanilides. The most active compound, 4-chloro-2-methoxy-N-(3,4-dichlorophenyl)benzothioamide (4e), had a minimal inhibition concentration (MIC) against M. tuberculosis of 2 μmol L(-1), which was better than the activity of the previously published corresponding salicylanilide.
650    _2
$a anilidy $x chemická syntéza $x chemie $x farmakologie $7 D000813
650    _2
$a antibakteriální látky $x chemická syntéza $x chemie $x farmakologie $7 D000900
650    _2
$a protinádorové látky $x chemická syntéza $x chemie $x farmakologie $7 D000970
650    _2
$a viabilita buněk $x účinky léků $7 D002470
650    _2
$a vztah mezi dávkou a účinkem léčiva $7 D004305
650    _2
$a screeningové testy protinádorových léčiv $7 D004354
650    _2
$a inhibitory enzymů $x chemická syntéza $x chemie $x farmakologie $7 D004791
650    _2
$a buňky Hep G2 $7 D056945
650    _2
$a lidé $7 D006801
650    _2
$a isocitrátlyasa $x antagonisté a inhibitory $x metabolismus $7 D007522
650    _2
$a mikrobiální testy citlivosti $7 D008826
650    _2
$a Mycobacterium avium $x účinky léků $7 D009162
650    _2
$a Mycobacterium kansasii $x účinky léků $7 D019909
650    _2
$a Mycobacterium tuberculosis $x účinky léků $7 D009169
650    _2
$a vztahy mezi strukturou a aktivitou $7 D013329
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Novotná, Eva $u Department of Bicochemical Sciences, Faculty of Pharmacy in Hradec Králové, Charles University in Prague, Hradec Králové, Czech Republic
700    1_
$a Volková, Marie $u Department of Pharmacology and Toxicology, Faculty of Pharmacy in Hradec Králové, Charles University in Prague, Hradec Králové, Czech Republic $7 xx0213299
700    1_
$a Stolaříková, Jiřina $u Laboratory for Mycobacterial Diagnostics and TB, Institute of Public Health in Ostrava, Ostrava, Czech Republic $7 xx0142458
700    1_
$a Trejtnar, František $u Department of Pharmacology and Toxicology, Faculty of Pharmacy in Hradec Králové, Charles University in Prague, Hradec Králové, Czech Republic $7 xx0143079
700    1_
$a Vinšová, Jarmila, $u Department of Inorganic and Organic Chemistry, Faculty of Pharmacy in Hradec Králové, Charles University in Prague, Hradec Králové, Czech Republic $d 1951- $7 nlk19990073991
773    0_
$w MED00001628 $t European journal of medicinal chemistry $x 1768-3254 $g Roč. 56(2012), s. 387-395
856    41
$u https://pubmed.ncbi.nlm.nih.gov/22907036 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20130703 $b ABA008
991    __
$a 20181212112316 $b ABA008
999    __
$a ok $b bmc $g 988022 $s 822722
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2012 $b 56 $d 387-395 $i 1768-3254 $m European journal of medicinal chemistry $n Eur J Med Chem $x MED00001628
GRA    __
$a NS10367 $p MZ0
GRA    __
$a NT13346 $p MZ0
LZP    __
$a Pubmed-20130703

Find record

Citation metrics

Archiving options